Bryant Moeller

Could calcium levels serve as a possible prognostic marker for in-hospital mortality among patients with pulmonary embolism?

Is there a significant relationship between obstructive impairment and the low forced expiratory volumes frequently seen in patients with CTEPH?

Are chronic respiratory symptoms in young adults possible warning signs of cardiovascular disease and all-cause mortality later in life?

The prospective SATICOVID19 study provides a detailed analysis of characteristics of invasively ventilated patients with COVID-19 in 63 ICUs in Argentina.

Is the 2018 World Symposium on Pulmonary Hypertension definition of pre-capillary pulmonary hypertension beneficial in clinical practice?

Avoiding intubation and mechanical ventilation during subcutaneous pump implantation under local anesthesia and conscious analgosedation was feasible in patients with pulmonary arterial hypertension.

Pulse rate variability as detected by pulse oximetry could serve as a useful biomarker for stroke risk stratification in patients with obstructive sleep apnea.

Riociguat may be a useful option for patients with pulmonary arterial hypertension in whom phosphodiesterase-5 inhibitor treatment is insufficient.

Although the mortality of patients with high-risk pulmonary embolism has decreased over time, the decrease cannot be attributed to improved treatments for pulmonary embolism.

Patients with pulmonary arterial hypertension (PAH) who were treated with treprostinil using an implantable infusion pump experienced few serious complications.